Literature DB >> 12100165

Characterization of granulocyte colony-stimulating factor receptor expressed on human lymphocytes.

Keiko Morikawa1, Shigeru Morikawa, Masahiko Nakamura, Toshio Miyawaki.   

Abstract

We have studied the characterization of granulocyte colony-stimulating factor receptor (G-CSFR) in human lymphocytes. About one-third to one-quarter of the B lymphocytes from peripheral B-cell sources displayed G-CSF binding on the two-colour immunofluorescence study. The rate of G-CSFR-expressing (G-CSFR+) B cells was higher in bone marrow and cord blood than in peripheral blood, spleen and tonsil. G-CSFR expression was greater in the surface immunoglobulin D (IgD)-positive (sIgD+) B-cell population, but scarce in the sIgD- B-cell population. In tonsil, G-CSFR+ B cells were present among the cells with naive B and germinal-centre B phenotypes, but those with memory B phenotype were rarely found on triple-colour immunofluorescence analysis. Mitogen-activated, but not resting, T lymphocytes also showed G-CSF binding. Several continuous T- and B-cell lines expressed functional G-CSFR, because the addition of G-CSF enhanced the proliferative response of these cell lines. A sequence analysis of G-CSFR mRNA isoforms obtained from the T and B cells revealed that G-CSFR was derived from class I and class IV mRNA. Our results indicated that G-CSFR was constitutively expressed on the B-cell surface and was inducible in T cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12100165     DOI: 10.1046/j.1365-2141.2002.03574.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  17 in total

Review 1.  Are there any new insights for G-CSF and/or AMD3100 in chemotherapy of haematological malignants?

Authors:  Zhao-Hua Shen; Dong-Feng Zeng; Ying-Ying Ma; Xi Zhang; Cheng Zhang; Pei-Yan Kong
Journal:  Med Oncol       Date:  2015-11-02       Impact factor: 3.064

2.  Neuroprotective effects of G-CSF administration in microglia-mediated reactive T cell activation in vitro.

Authors:  Wei Peng
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

3.  Effect of administration timing of postchemotherapy granulocyte colony-stimulating factor on host-immune cell recovery and CD8+ T-cell response.

Authors:  Mohamed Labib Salem; Mohamed Nassef; Soha G R Abdel Salam; Abdelaziz Zidan; Mohamed H Mahmoud; Gamal Badr; Mark Rubinstein; David Cole
Journal:  J Immunotoxicol       Date:  2016-07-15       Impact factor: 3.000

4.  Expression of granulocyte colony stimulating factor receptor in human colorectal cancer.

Authors:  X Yang; F Liu; Z Xu; C Chen; X Wu; G Li; J Li
Journal:  Postgrad Med J       Date:  2005-05       Impact factor: 2.401

5.  Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cells.

Authors:  Maura Rossetti; Silvia Gregori; Maria Grazia Roncarolo
Journal:  Eur J Immunol       Date:  2010-10-19       Impact factor: 5.532

6.  Critical role for granulocyte colony-stimulating factor in inflammatory arthritis.

Authors:  Kate E Lawlor; Ian K Campbell; Donald Metcalf; Kristy O'Donnell; Annemarie van Nieuwenhuijze; Andrew W Roberts; Ian P Wicks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-22       Impact factor: 11.205

7.  Granulocyte colony-stimulating factor impairs CD8(+) T cell functionality by interfering with central activation elements.

Authors:  C E Bunse; S Tischer; J Lahrberg; M Oelke; C Figueiredo; R Blasczyk; B Eiz-Vesper
Journal:  Clin Exp Immunol       Date:  2016-05-13       Impact factor: 4.330

8.  Inference of surface membrane factors of HIV-1 infection through functional interaction networks.

Authors:  Samira Jaeger; Gokhan Ertaylan; David van Dijk; Ulf Leser; Peter Sloot
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

9.  Granulocyte colony-stimulating factor affects the distribution and clonality of TRGV and TRDV repertoire of T cells and graft-versus-host disease.

Authors:  Li Xuan; Xiuli Wu; Yu Zhang; Zhiping Fan; Yiwen Ling; Fen Huang; Fuhua Zhang; Xiao Zhai; Qifa Liu
Journal:  J Transl Med       Date:  2011-12-15       Impact factor: 5.531

10.  Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies.

Authors:  Amy M Trottier; Lawrence J Druhan; Ira L Kraft; Amanda Lance; Simone Feurstein; Maria Helgeson; Jeremy P Segal; Soma Das; Belinda R Avalos; Lucy A Godley
Journal:  Blood Adv       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.